Small-Cap’s Subsidiary Gets Closer to Development of Next Generation Solar Technology

In the small cap world, there is small and, then, there is, well, small. There are those aggressive little startup companies that are only improving because there is no other way but up, and there are those which have acquired sufficient size to reach for higher things, including the sun.

Kirkland, Washington-headquartered LadyBug Resource Group (OTCBB:LBRG) is among the latter firm, having announced in mid-September that its subsidiary, something called New Solar Electricity Corporation, is finishing Phase One in the development of a revolutionary solar concentrator.
Solar Tracer is geared to use concentrating solar power technology to capture energy from the sun and make that energy into heat to run steam turbine generators. New Solar management harbors the opinion that its Solar Tracer will best its competition among the current generation of linear concentrator systems. Phase One is all about identifying a low-cost high-reflectivity surface material for use in the concentrator unit, testing multiple surface types and materials and determining their reflectivity. Most other such systems use steel board and glass mirror/plastic mirror sheet for their reflective surface, which can be quite expensive.

LBRG is in the business of buying up and licensing breakthrough technologies, patents and trade secrets in the energy, health and intellectual property sectors. Nor does this parent company content itself with one spinoff firm. Besides New Solar, there is also Inner Path Health Corporation, which licenses health and wellness products, as well as skin, hair and beauty consumer products.

Among LBGR’s other recent coups came on the last day of August, when the parent company signed a Letter of Intent to acquire Men’s Medical Corporation, to which the company plans to change its name once the i’s are dotted and t’s are crossed – likely the end of this month. Men’s Medical will then hold the license for a treatment process for men’s erectile dysfunction called The Boston Method – a major conquest, given that the market for such products is expected to expand to more than $1.7 billion by the end of this year.

Such a variety of activities have worked their way into the bottom line of this growing company. LBRG’s stock price is in the middle of a 52-week trading range at around 60 cents a share, down dramatically from its peak of 80 cents achieved last May, but an improvement on its gulch of 30 cents from June. But with the latest on solar energy innovations announced by the New Solar subsidiary, investors are likely to “warm” to this company, and investigate possibly including LBRG among their holdings before too long.

Related Stories